Rhythm Biosciences Limited (ASX:RHY)
Australia · Delayed Price · Currency is AUD 0.0870
+0.0020 (2.35%)
Jul 17, 2026, 4:10 PM AEST
Rhythm Biosciences Market Cap
Rhythm Biosciences has a market cap or net worth of 30.79 million as of July 17, 2026. Its market cap has increased by 90.13% in one year.
Market Cap
30.79M
Enterprise Value
29.32M
Revenue
1.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
ChartMarket Cap Chart
Since December 7, 2017, Rhythm Biosciences's market cap has decreased from 32.74M to 30.79M, a decrease of -5.98%. That is a compound annual growth rate of -0.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 30.79M | -30.06% |
| Dec 31, 2025 | 44.02M | 78.41% |
| Dec 31, 2024 | 24.67M | -17.35% |
| Dec 29, 2023 | 29.85M | -86.11% |
| Dec 30, 2022 | 215.00M | -33.62% |
| Dec 31, 2021 | 323.86M | 83.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 447.11M |
| Healius | 283.20M |
| Monash IVF Group | 274.69M |
| Cryosite | 63.45M |
| INOVIQ | 31.67M |
| BCAL Diagnostics | 28.02M |
| Microba Life Sciences | 25.58M |
| ImExHS | 16.76M |